๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)
Hong Kong flag Hong Kong ยท Delayed Price ยท Currency is HKD
5.34
-0.09 (-1.57%)
Nov 20, 2026, 4:08 PM HKT

HKG:3613 Financials Overview

Millions HKD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,3541,5131,6121,5251,7311,556
Revenue Growth
-10.56%-6.10%5.68%-11.91%11.24%18.31%
Gross Profit
847.21925.581,0651,0471,1501,120
Operating Income
426.25476574.06623.91804.49772.13
Net Income
360.55397.22500.28540.39645.88607.84
Earnings Per Share
0.430.470.600.650.770.73
EPS Growth
-9.23%-20.60%-7.42%-16.33%6.26%12.05%

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Inter-Segment Elimination
-332.78-336.6-308.86-357.36-469.73-678.32
Overseas
364.16406.46402.62482.44472.26443.6
Mainland China
201.35266.1248.76228.63528.45578.8
Hong Kong
1,1211,1771,2691,1711,2001,212
Total
1,3541,5131,6121,5251,7311,556

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2,2172,2901,8332,3982,2622,293
Total Debt
125.8126.54123.42131.81103.08128.48
Net Cash (Debt)
2,0922,1641,7102,2662,1592,165
Net Cash Growth
-3.34%26.57%-24.57%4.96%-0.26%22.98%
Net Cash Per Share
2.502.582.042.712.582.59

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
621.93829.52-217.25460.83547.44777.17
Capital Expenditures
-27.41-41.18-43.17-21.87-38.51-23.43
Free Cash Flow
594.53788.34-260.42438.97508.94753.74
Free Cash Flow Growth
-24.59%---13.75%-32.48%630.55%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
62.59%61.16%66.10%68.67%66.44%71.95%
Operating Margin
31.49%31.45%35.62%40.91%46.47%49.62%
Pretax Margin
33.13%33.35%39.08%45.10%47.71%50.02%
Profit Margin
26.64%26.25%31.04%35.44%37.31%39.06%
FCF Margin
43.92%52.09%-16.16%28.79%29.40%48.44%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.3700.3700.3500.3300.3300.280
Dividend Per Share Growth
14.29%5.71%6.06%0%17.86%16.67%
Dividend Yield
6.93%4.37%3.99%2.72%2.88%2.09%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
12.4017.8314.6918.8114.8518.48
Forward PE
10.0812.3510.5312.3715.4317.23
P/FCF Ratio
7.528.98-23.1518.8514.90
PS Ratio
3.304.684.566.665.547.22